Public Health Archives - Page 34 of 34

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

VideaHealth Lands No. 28 Spot on 2025 Inc. 5000 Fastest-Growing Companies List

August 12, 2025

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

August 11, 2025

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

August 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Washington Trust Wins Exemplary Worksite Health Award for Ninth Consecutive Year

Nearly Half of Americans Delay Healthcare Due to Cost and Insurance Barriers, Madaket Health Survey Finds

Majority of Americans Support Water Fluoridation, New Survey Finds

Stronger Gun Laws Linked to Fewer Firearm Suicides, While Socioeconomic Factors Drive Homicides, Northwell Health Study Finds

AHF Launches National Ad Campaigns Targeting HIV Stigma and Promoting STD Testing

Most Read

ZAP Surgical Marks 5,000th Patient Treated with ZAP-X Gyroscopic Radiosurgery Platform

Bionova Scientific Opens Texas Facility to Expand Plasmid DNA Production for Cell and Gene Therapy Market

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

OM1 Expands Neurology Network by 500,000 Patients, Boosting Real-World Evidence Capabilities

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

VideaHealth Lands No. 28 Spot on 2025 Inc. 5000 Fastest-Growing Companies List

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US